LIVE Webinar | What Are the Current Treatment Options for AML?

March 22, 2019

  Register Now

As a patient, how can I explore all the treatment options available for acute myeloid leukemia (AML)? What are the considerations when choosing treatment that’s right for me? During this LIVE webinar, an expert panel, including Dr. Uma Borate of Oregon Health & Science University, will help viewers understand more about the evolving field of AML treatment, identifying prognostic factors, determining patient subtypes, setting treatment goals and selecting a suitable course of treatment. 

Watch online on Friday, March 22 at 9 AM Pacific (Noon Eastern, 11 AM Central) for a one-hour virtual webinar. You’ll also have the opportunity to get your questions answered by the panel. Send questions in advance to

REGISTER NOW to learn about: 

  • An overview of current treatment options, including chemotherapy, targeted therapy and treatment
  • The role of genetic testing in AML care
  • Treatment available for refractory AML
  • Choosing treatment that is right for you
  • Common physical treatment side effects and approaches for management
  • Address the emotional aspects of living with AML and coping strategies

  Register Now
Host & Guests

Host, Patient Power Co-Founder, CLL Patient and Advocate


Assistant Professor of Medicine, School of Medicine

Oregon Health & Science University

Patient Advocate

Register Now

I understand that the information I've provided will only be accessed by Patient Power, LLC and its contracted third parties to mail (and email) helpful information about cancer and related products and services. Patient Power will not sell or transfer my name or contact information to any third party for their marketing use.

Log in    Already a member? Log in now.

Community Member Account

Help us to better understand you

Stay Informed

Can't read the security code? Refresh Code

If you are having issues with the registration form, please call (877) 668-2858 to register over the phone or email

This is a Patient Empowerment Network program produced by Patient Power in partnership with The Leukemia & Lymphoma Society. We thank Celgene, Daiichi Sankyo, Jazz Pharmaceuticals and Novartis for their support.


Patient Empowerment Network
The Leukemia & Lymphoma Society (LLS)
Patient Power
Rejoignez notre communauté S'inscrire aux événements Lisez notre dernier blog

Page last updated on March 8, 2019